International Chemical Investors Group
  • HOME
  • OUR APPROACH
  • OUR INVESTMENTS
    • Market Oriented Platforms
    • Companies
  • NEWS
  • CONTACT

ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group

by Infrastructure Support | Jul 26, 2019 | News

26. July 2019 CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective...

LATEST ICIG NEWS

Evonik sells Lülsdorf site to ICIG – First step in the divestment of Performance Materials

06 April 2023 Established chemical group plans to invest substantially in the site Extensive employment safeguards agreed Transfer to new owner planned for mid-2023...

International Chemical Investors has closed the acquisition of inprotec from Paragon Partners

18 November 2022 International Chemical Investors (ICIG) has successfully closed the acquisition of inprotec AG from Paragon Partners. inprotec offers its clients...

International Chemical Investors completes the acquisition of Benvic from Investindustrial

17 November 2022 International Chemical Investors (ICIG) has successfully completed the acquisition of the compounds business of Benvic Group SAS from PVC Europe Group...

International Chemical Investors (ICIG) to acquire Nisso’s MSSA to further expand its chlor-alkali operations

16 November 2022 International Chemical Investors (ICIG) has made a firm and binding offer to acquire sodium metal specialist Métaux Spéciaux (MSSA) from Nippon Soda....

⤏ All News